Accelerated Radiotherapy Outcomes in Women (Long Term Outcomes of a Randomized Trial of Breast Irradiation Schedules After Lumpectomy in Women With Node-Negative Breast Cancer)(AROW)
This study is evaluating the long-term outcomes of women in a randomized trial that compared
accelerated whole breast irradiation (42.5 Gy in 16 fractions over 22 days) to a longer
conventional schedule of whole breast irradiation (50 Gy in 25 fractions over 35 days)
following breast-conserving surgery. The results reported at 5 years demonstrated
equivalence for these two different radiation schedules for the effect of local recurrence
in the breast and cosmetic outcome. Emerging data has suggested that accelerated or shorter
radiation schedules may potentially be associated with an increased risk of late morbidity
of the skin, soft tissue and the heart at 10 years and beyond. The purpose of this study is
to evaluate the long term outcomes of women randomized in the trial. The outcomes evaluated
will include cosmetic outcome and cardiac disease as a measure of late radiation morbidity
and local breast recurrence as a measure of effectiveness.
Only patients recruited into the "Randomized Trial of Hypofractionated Radiotherapy
Post-Lumpectomy in Women with Node Negative Breast Cancer" study are eligible to be
enrolled into this study.
Observational
Time Perspective: Prospective
Timothy Whelan, MD
Study Chair
Juravinski Cancer Centre
Canada: Health Canada
OCOG-2003-AROW
NCT00156130
October 2003
Name | Location |
---|